Prothena Corp Public (PRTA) Other Working Capital Changes (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Other Working Capital Changes came in at -$719000.0 in Q1 2026, down 11.47% year-on-year from -$812180.4 in Q1 2025, and down 1.41% quarter-over-quarter from -$709000.0 in Q4 2025.
Prothena Corp Public (PRTA) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Prothena Corp Public's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$719000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 11.47% year-over-year to -$719000.0 in Q1 2026; TTM through Mar 2026 was -$2.8 million, a 10.02% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 million, down 20.48% from the prior year.
- Other Working Capital Changes eased to -$719000.0 in Q1 2026 per PRTA's latest filing, from -$709000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $50.4 million in Q4 2024 and bottomed at -$58.4 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$1.6 million (2023), against an average of -$3.5 million.
- Across the five-year window, Other Working Capital Changes soared 77.02% in 2024 and sank 76.71% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$1.6 million in 2022, then increased by 0.77% to -$1.5 million in 2023, then surged by 57.97% to -$651000.0 in 2024, then slipped by 8.91% to -$709000.0 in 2025, then declined by 1.41% to -$719000.0 in 2026.
- Per Business Quant, the three latest PRTA Other Working Capital Changes figures stand at -$719000.0 (Q1 2026), -$709000.0 (Q4 2025), and -$699000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | -2.42 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Mar 31, 2025 | 843,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Dec 31, 2024 | 50.45 Mn |
| Dec 31, 2024 | 50.45 Mn |
| Dec 31, 2024 | 50.45 Mn |
| Sep 30, 2024 | -58.42 Mn |
| Sep 30, 2024 | -58.42 Mn |